Back to search

Netherlands· NL-c6f0301d7739

Lyvdelzi 10 mg harde capsules

A seladelpar product containing seladelpar lysine 2-water, registered in Netherlands by Gilead Sciences Ireland UC. The same ATC class is registered in 11 of our 19 countries.

ATC A05AX07

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedLyvdelzi 10 mg harde capsulesATCA05AX07REGISTER NO.NL-c6f0301d7739PACKS LISTED1CHECKEDSeptember 29, 2026

Where it is registered

Seladelpar is registered in 11 of 19 countries.

Countries holding a registration under ATC A05AX07 (seladelpar), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 7 of them publish a price we can compare per daily dose

Seladelpar · ATC A05AX07

11 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Spainprice
  • Switzerlandprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

CBG-MEB (Netherlands)
Active substance
SELADELPAR LYSINE 2-WATER
Manufacturer
Gilead Sciences Ireland UC
Country
Netherlands (NL)
ATC code
A05AX07
ATC class
Seladelpar
Defined daily dose
10 mg, O
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    EU/1/24/1898

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Seladelpar in 6 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All seladelpar products

Authorised across Europe · EMA

The same active substance is authorised in 3 EEA countries. Names it is sold under:

  • Iceland · Lyvdelzi
  • Liechtenstein · Lyvdelzi
  • Norway · Lyvdelzi

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/b5cf2bba-9b8d-4363-be69-cd2cdc9c0a07
GET /v1/drugs/b5cf2bba-9b8d-4363-be69-cd2cdc9c0a07?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Capsule, hard",
  "route": "Oraal gebruik",
  "soort": null,
  "source": "cbg_meb",
  "smpc_url": "https://www.ema.europa.eu/en/documents/product-information/lyvdelzi-epar-product-information_nl.pdf",
  "strength": null,
  "atc_label": "Seladelpar",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/cp133060",
  "excipients": [
    "BUTYLHYDROXYTOLUEEN (E 321)",
    "CELLULOSE, MICROKRISTALLIJN (E 460(i))",
    "CROSCARMELLOSE  NATRIUM  (E 468)",
    "GELATINE (E 441)",
    "IJZEROXIDE GEEL (E 172)",
    "IJZEROXIDE ROOD  (E 172)",
    "IJZEROXIDE ZWART (E 172)",
    "IJZEROXIDE ZWART (E 172)",
    "INDIGOKARMIJN (E 132)",
    "KALIUMHYDROXIDE (E 525)",
    "MAGNESIUMSTEARAAT (E 470b)",
    "MANNITOL (D-) (E 421)",
    "NATRIUMHYDROXIDE (E 524)",
    "POVIDON (E 1201)",
    "PROPYLEENGLYCOL (E 1520)",
    "PROPYLEENGLYCOL (E 1520)",
    "SCHELLAK (E 904)",
    "SCHELLAK (E 904)",
    "SILICIUMDIOXIDE (E 551)",
    "TITAANDIOXIDE (E 171)",
    "TITAANDIOXIDE (E 171)",
    "WITTE INKT",
    "ZWARTE INKT"
  ],
  "substances": [
    "SELADELPAR LYSINE 2-WATER"
  ],
  "leaflet_url": null,
  "authorised_at": "2025/02/20",
  "procedure_number": "EMEA/H/C/004692",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "EU/1/24/1898",
  "additional_monitoring": "Y"
}

See everything about seladelpar.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.